NCT07080814 The Effect of Balance Training Using a Dynamometric Platform in Patients Undergoing Total Knee Arthroplasty
| NCT ID | NCT07080814 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Knee Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-05-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total knee arthroplasty (TKA) is a common surgery used to treat advanced knee osteoarthritis, especially when other treatments no longer help. While the surgery often reduces pain and improves joint alignment, many patients still have problems with balance and movement afterward. This study will explore whether adding balance training using the Tecnobody ProKin system to standard physical therapy helps patients recover better after TKA. The researchers will measure balance, walking ability, leg strength, and body awareness (also called proprioception) using special equipment. The main goal is to test the hypothesis that technology-supported balance training improves recovery outcomes more effectively than standard rehabilitation alone.
Eligibility Criteria
Inclusion Criteria: * Patients who have undergone total knee arthroplasty within the past 2 years and are hospitalized at the Orthopedic Rehabilitation Clinic of Ankara Etlik City Hospital, Physical Therapy Hospital. * Able to fully bear weight on the operated lower extremity in the third postoperative week. * Willingness to participate and signing of the written informed consent form. Exclusion Criteria: * Bilateral knee arthroplasty * Age under 18 years * Receiving treatment at a physical therapy unit within the first 2 weeks after knee arthroplasty * Presence of significant visual or hearing impairment, active infection * Clinically unstable condition * Presence of central nervous system lesions (e.g., stroke, multiple sclerosis) * Presence of malignancy * Presence of a fracture in the lower extremity * Presence of any condition that would prevent participation in the treatment * History of lumbar disc surgery * History of previous surgery in the lower extremity * Presence of advanced osteoarthritis in the non-operated lower extremity
Contact & Investigator
Zeynep Alpoğuz Yilmaz, MD
PRINCIPAL INVESTIGATOR
Ankara Etlik City Hospital
Frequently Asked Questions
Who can join the NCT07080814 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07080814 currently recruiting?
Yes, NCT07080814 is actively recruiting participants. Contact the research team at zeynepalpoguz@gmail.com for enrollment information.
Where is the NCT07080814 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07080814 clinical trial?
NCT07080814 is sponsored by Ankara Etlik City Hospital. The principal investigator is Zeynep Alpoğuz Yilmaz, MD at Ankara Etlik City Hospital. The trial plans to enroll 46 participants.